Caffeine Was Associated With Shorter Continuous Positive Airway Pressure Treatment for Infants up to Eight Weeks Old

Manon Casabianca1, David Akouka1, Linda Maman2

  • 1Paediatric Emergency Department, Robert Debré University Hospital, Sorbonne University, Paris, France.

Insights

Caffeine administration in infants hospitalized for bronchiolitis significantly reduced the need for nutritional support and shortened the duration of respiratory support. This pilot study suggests caffeine may be a beneficial intervention for infants with bronchiolitis.

Area of Science:

  • Pediatrics
  • Neonatology
  • Respiratory Medicine

Background:

  • Bronchiolitis is a primary cause of infant hospitalization.
  • Current treatment options for bronchiolitis are limited.
  • Caffeine is known to stimulate respiratory function in infants.

Purpose of the Study:

  • To investigate the impact of caffeine on infants hospitalized with bronchiolitis.
  • To assess adverse events and the need for ventilatory and nutritional support.

Main Methods:

  • Observational study conducted in two Paris hospitals.
  • Recruited 186 infants up to 8 weeks old.
  • Compared outcomes between infants who received caffeine and those who did not.

Main Results:

  • Caffeine group required significantly less nutritional support (p < 0.001).
  • Shorter duration of continuous positive airway pressure (CPAP) in the caffeine group (4.1 days vs. 7.1 days, p = 0.003).
  • Caffeine was well tolerated with no significant adverse events reported.

Conclusions:

  • Caffeine administration reduced CPAP duration and nutritional support needs in infants with bronchiolitis.
  • Potential direct effect on the digestive system or overall improvement.
  • Results warrant confirmation through randomized controlled trials.
Abstract

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
430
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
307
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
224
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
397
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
578
Antiasthma Drugs: &#946;2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
380